Upper Gastrointestinal Biopsy
Publication Date: October 1, 2015
Key Points
Key Points
The purpose of the current guideline is to establish evidence-based practicing standards for the performance of biopsies of normal-appearing mucosa in the upper gastrointestinal tract.
Dyspepsia is defined according to the Rome III criteria, which include ≥1 of the following symptoms: bothersome postprandial fullness, early satiation, epigastric pain, and epigastric burning.
The guideline assumes no prior treatment for Helicobacter pylori (HP) infection.
Dyspepsia is defined according to the Rome III criteria, which include ≥1 of the following symptoms: bothersome postprandial fullness, early satiation, epigastric pain, and epigastric burning.
The guideline assumes no prior treatment for Helicobacter pylori (HP) infection.
Diagnosis
...riteria for Functional Dyspepsia...
...ointestinal Biopsy to Evaluate Dyspepsia in the...
Summary of Recommendations from the AGA Guideline on Upper-GI Biopsies to Evaluate Adult Dyspepsia
...Summary of Recomm...
...n patients undergoing EGD for dyspepsia as the...
...immunocompetent patients undergoing EGD...
In immunocompromised patients undergoing EGD f...
...g biopsies from the normal-appearing gastric bo...
...are obtained from the normal-appear...
...patients undergoing EGD for dyspepsia as t...
...immunocompromised patients undergoing EGD fo...
...n biopsies are obtained from the normal-appeari...
Locations of Gastric Biopsy Recommended by the Updated Sydney System
...Gastric Biopsy Recommended by the...